At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study
2020 ◽
Vol 261
◽
pp. 221-229
◽
2019 ◽
Vol 29
◽
pp. S171-S172
◽
2021 ◽
2020 ◽
Vol 62
(9)
◽
pp. 746-756